These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9365820)

  • 1. Dose-dependent cardiovascular, renal, and endocrine effects of furosemide in conscious lambs.
    Patel A; Smith FG
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1101-7. PubMed ID: 9365820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal nerves do not modulate the renal and endocrine responses to furosemide in conscious lambs.
    Smith FG; Strack AM; de Wildt SN
    Can J Physiol Pharmacol; 1996 May; 74(5):614-20. PubMed ID: 8884028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine, and renal responses to furosemide in conscious lambs.
    de Wildt SN; Smith FG
    Can J Physiol Pharmacol; 1997 Apr; 75(4):263-70. PubMed ID: 9196851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent cardiovascular, renal and endocrine responses to furosemide in conscious lambs.
    Thomson JJ; Smith FG
    Clin Exp Pharmacol Physiol; 2004; 31(1-2):70-5. PubMed ID: 14756687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic furosemide treatment alters renal responses to furosemide in conscious lambs.
    Smith FG; Sener A; Hyland P
    Pediatr Nephrol; 2000 Sep; 14(10-11):916-21. PubMed ID: 10975299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and renin responses to furosemide in conscious lambs during postnatal maturation.
    Smith FG; Abraham J
    Can J Physiol Pharmacol; 1995 Jan; 73(1):107-12. PubMed ID: 7600440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 produces no renal vasoconstriction in conscious newborn lambs.
    Smith FG; Nohara N; Patel A; Sener A
    Pediatr Nephrol; 2002 Nov; 17(11):889-95. PubMed ID: 12432428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
    Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
    J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous bradykinin and the renin and pressor responses to furosemide in humans.
    Murphey LJ; Kumar S; Brown NJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):644-8. PubMed ID: 11046100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of systemic and renal haemodynamics by kappa-opioids in conscious lambs.
    Qi W; Smith FG
    Exp Physiol; 2006 Sep; 91(5):877-85. PubMed ID: 16728455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renal denervation on cardiovascular response to furosemide in conscious lambs.
    Smith FG; Strack AM
    Am J Physiol; 1995 Jul; 269(1 Pt 2):H149-52. PubMed ID: 7631844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
    Mulder H; Schopman W; van der Lely AJ; Schopman W
    Horm Metab Res; 1987 Feb; 19(2):80-3. PubMed ID: 3549504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal interstitial hydrostatic pressure and natriuretic response to high doses of angiotensin II in pregnant rats.
    Yu T; Khraibi AA
    Am J Hypertens; 2006 Mar; 19(3):300-5. PubMed ID: 16500518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.